alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.2**

** **

ZORAN CORPORATION

CERTIFICATIONPURSUANT TO

18 U.S.C. SECTION1350,

AS ADOPTEDPURSUANT TO

SECTION 906 OF THESARBANES-OXLEY ACT OF 2002

 

In connection with theQuarterly Report of Zoran Corporation (the “Company”) on Form 10-Q for theperiod ended March 31, 2006, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Karl Schneider, Senior VicePresident, Finance and Chief Financial Officer of the Company, hereby certify,pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 ofthe Sarbanes-Oxley Act of 2002, that:

 

(1)  The Report fully complies withthe requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

(2)  The information contained in theReport fairly presents, in all material respects, the financial condition andresult of operations of the Company.

 

 
| Dated:  May 10,  2006 | /s/ Karl Schneider                  |   |
|----------------------------|-------------------------------------|--------|
|                       | Karl Schneider                      |
|                       | Senior Vice President,  Finance and |
|                       | Chief Financial Officer             |

 

----
I 

115TH CONGRESS 

1ST SESSION H. R. 1754 

To amend the Federal Trade Commission Act to clarify the scope of the 

exception for common carriers. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 28, 2017 

Mr. LATTA (for himself and Mr. OLSON) introduced the following bill; which 

was referred to the Committee on Energy and Commerce, and in addition 

to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions 

as fall within the jurisdiction of the committee concerned 

A BILL 

To amend the Federal Trade Commission Act to clarify 

the scope of the exception for common carriers. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CLARIFICATION OF SCOPE OF COMMON CAR4 RIER EXCEPTION. 

5 The Federal Trade Commission Act (15 U.S.C. 41 

6 et seq.) is amended— 

7 (1) in section 5(a)(2), by inserting ‘‘insofar as 

8 they are’’ after ‘‘common carriers’’; and 

9 (2) in section 6— 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 1754 IH

1 (A) by inserting ‘‘insofar as they are’’ after 

2 ‘‘common carriers’’ each place it appears; and 

3 (B) by inserting ‘‘insofar as it is’’ after 

4 ‘‘common carrier’’ each place it appears. 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS
Exhibit 32.1

CERTIFICATION PURSUANT TO 
18 U.S.C. Section 1350, 
AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of First American Scientific Corp. (the "Company") on Form 10-Q for the period ended March 31, 2008, as filed with the Securities and Exchange Commission on the date here of (the "report"), I, John Brian Nichols, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|   

Dated this 19th day of May, 2008.

JOHN BRIAN NICHOLS
John Brian Nichols, President and ChiefExecutive Officer













---
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       4,772,271
<SECURITIES>                                 6,271,022
<RECEIVABLES>                                2,293,276
<ALLOWANCES>                                         0
<INVENTORY>                                    500,095
<CURRENT-ASSETS>                            14,007,078
<PP&E>                                       4,294,404
<DEPRECIATION>                               1,487,688
<TOTAL-ASSETS>                              19,838,595
<CURRENT-LIABILITIES>                        7,473,709
<BONDS>                                              0
<COMMON>                                         7,164
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                  12,286,587
<TOTAL-LIABILITY-AND-EQUITY>                19,838,595
<SALES>                                        603,746
<TOTAL-REVENUES>                             2,328,109
<CGS>                                          558,440
<TOTAL-COSTS>                                2,114,459
<OTHER-EXPENSES>                                   658
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             171,752
<INCOME-PRETAX>                                220,713
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            220,713
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   220,713
<EPS-PRIMARY>                                     0.03
<EPS-DILUTED>                                        0
        

</TABLE>
EXHIBIT 32.2

SECTION 1350

CERTIFICATION OF CHIEF FINANCIAL OFFICER

In connection with the Annual Report of Union Drilling, Inc. (the Company) on Form 10-K for the year ended December 31, 2010, as filed
with the Securities and Exchange Commission (the Report), Tina L. Castillo, Chief Financial Officer of the Company, does hereby certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to her
knowledge:



| | 1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------



By:

/s/ Tina L. CastilloName:

Tina L. CastilloTitle:

Vice President, Chief Financial Officer and TreasurerDate:

March 4, 2011
EXHIBIT 32.3

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Annual Report on Form 10-K of UnitedGlobalCom, Inc. (the "Company") for the year ended December 31, 2003, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Charles H.R. Bracken, Co-Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



|Date: March 15, 2004 |  | /s/CHARLES H.R. BRACKENCharles H.R. Bracken Co-Chief Financial Officer
|-------------------- |  | ----------------------------------------------------------------------

---

QuickLinks
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Prepared by NRC StaffGeneric  Environmental Impact Statement for License Renewal of Nuclear Plants  (NUREG-1437)

# Generic Environmental Impact Statement for License Renewal of Nuclear Plants—Final Report (NUREG-1437, Revision 1)

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG-1437, Volume 1, Revision 1 – Main Report (PDF - 9.94 MB)
        - NUREG-1437, Volume 2, Revision 1 – Public Comments (PDF - 2.10 MB)
        - NUREG-1437, Volume 3, Revision 1 – Appendices (PDF - 30.29 MB)

## Publication Information

**Manuscript Completed:**May 2013**Date Published:**June 2013

Office of Nuclear Regulatory ResearchU.S. Nuclear Regulatory CommissionWashington, DC 20555-0001

Availability Notice

## Abstract

U.S. Nuclear Regulatory Commission (NRC) regulations allow for the renewal of commercial nuclear power plant operating licenses. To support the license renewal environmental review process, the NRC published the *Generic Environmental Impact Statement for License Renewal of Nuclear Plants*(GEIS) in 1996. The proposed action considered in the GEIS is the renewal of nuclear power plant operating licenses.

Since publication of the GEIS, approximately 40 plant sites (70 reactor units) have applied for license renewal and undergone environmental reviews, the results of which were published as supplements to the 1996 GEIS. This GEIS revision reviews and reevaluates the issues and findings of the 1996 GEIS. Lessons learned and knowledge gained during previous license renewal reviews provide a significant source of new information for this assessment. In addition, new research, findings, public comments, and other information were considered in evaluating the significance of impacts associated with license renewal.

The intent of the GEIS is to determine which issues would result in the same impact at all nuclear power plants and which issues could result in different levels of impact at different plants and thus require a plant-specific analysis for impact determinations. The GEIS revision identifies 78 environmental impact issues for consideration in license renewal environmental reviews, 59 of which have been determined to be generic to all plant sites. The GEIS also evaluates a full range of alternatives to the proposed action. For most impact areas, the proposed action would have impacts that would be similar to or less than impacts of the alternatives, in large part because most alternatives would require new power plant construction, whereas the proposed action would not.

Page Last Reviewed/Updated Wednesday, March 24, 2021
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE LCA-VISION INC.
CONDENSED CONSOLIDATED BALANCE SHEET AT SEPTEMBER 30, 1998, AND THE RELATED
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 1998, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENT.
</LEGEND>
<CIK> 0001003130
<NAME> LCA-VISION INC.
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                              JAN-1-1998
<PERIOD-END>                               SEP-30-1998
<EXCHANGE-RATE>                                0.00001
<CASH>                                           3,881
<SECURITIES>                                         0
<RECEIVABLES>                                    1,957
<ALLOWANCES>                                       354
<INVENTORY>                                         46
<CURRENT-ASSETS>                                 7,291
<PP&E>                                          17,401
<DEPRECIATION>                                   7,222
<TOTAL-ASSETS>                                  30,689
<CURRENT-LIABILITIES>                            4,661
<BONDS>                                          3,185
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     10,850
<COMMON>                                            99
<OTHER-SE>                                      11,894
<TOTAL-LIABILITY-AND-EQUITY>                    30,689
<SALES>                                              0
<TOTAL-REVENUES>                                25,323
<CGS>                                                0
<TOTAL-COSTS>                                   28,129
<OTHER-EXPENSES>                                10,500
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 698
<INCOME-PRETAX>                               (13,460)
<INCOME-TAX>                                       145
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (13,605)
<EPS-PRIMARY>                                    (.38)
<EPS-DILUTED>                                    (.38)
        

</TABLE>
H. R. 1900 

One Hundred Fifteenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Wednesday, 

the third day of January, two thousand and eighteen 

An Act 

To designate the Veterans Memorial and Museum in Columbus, Ohio, as the National 

Veterans Memorial and Museum, and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘National Veterans Memorial 

and Museum Act’’. 

SEC. 2. DESIGNATION OF NATIONAL VETERANS MEMORIAL AND 

MUSEUM. 

(a) DESIGNATION.—Subject to the condition described in subsection (b), the memorial and museum that is, as of the date 

of the enactment of this Act, being constructed on an approximately 

7-acre area on West Broad Street, Columbus, Ohio, bounded by 

the Scioto River and the Scioto Greenway, shall be designated 

as the ‘‘National Veterans Memorial and Museum’’. 

(b) WITHDRAWAL OF DESIGNATION.—The designation under subsection (a) may be withdrawn no earlier than 5 years after the 

date on which the museum opens the public, pursuant to an Act 

of Congress, if the progress and operation of the museum are 

found to be unsatisfactory based on the report submitted under 

subsection (c). 

(c) REPORT TO CONGRESS.— (1) IN GENERAL.—As a condition of the designation under 

subsection (a), the director of the memorial and museum 

described in that subsection shall submit to Congress a report 

on the memorial and museum by not later than the date 

specified in paragraph (2). Such report shall include each of 

the following: 

(A) The projected budget for the memorial and museum 

for the 5-year period beginning on the date the memorial 

and museum is expected to open to the public. 

(B) A description of the outreach conducted by the 

memorial and museum to veterans across the United States 

to receive input about the design and contents of the memorial and museum. 

(C) A description of the process by which decisions 

are made about the contents of the exhibits displayed at 

the memorial and museum. 

(D) A description of the organizational structure of 

the memorial and museum. 

(E) A copy of the bylaws and rules of the memorial 

and museum. 
H. R. 1900—2 

(F) A list of any organizations or entities that have 

accredited the memorial and museum. 

(2) DEADLINE FOR REPORT.—The date specified in this paragraph is the earlier of the following dates: 

(A) The date that is 90 days after the date of the 

enactment of this Act. 

(B) The date that is 30 days before the date on which 

the memorial and museum is first open to the public. 

(d) EFFECT OF DESIGNATION.—The national memorial and 

museum designated by subsection (a) is not a unit of the National 

Park System, and the designation of the national memorial and 

museum shall not be construed to require Federal funds to be 

expended for any purpose related to the national memorial and 

museum. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
No. 91-6100.

#### Dailey *v.*Kemna, Superintendent, Western Missouri Correctional Center.

C. A. 8th Cir. Certiorari denied.
Slip Op. 02-136

UNITED STATES COURT OF INTERNATIONAL TRADE

__________________________________________

ALTOS HORNOS DE MEXICO, S.A. DE C.V., :

:

Plaintiff, :

:

v. :

:

UNITED STATES OF AMERICA, :

:

Defendant, : Before: Wallach, Judge

: Consol. Court No.: 01-00018

and :

:

BETHLEHEM STEEL CORPORATION, : 

and UNITED STATES STEEL :

CORPORATION, :

:

Defendant-Intervenors. :

__________________________________________:

JUDGMENT ORDER

Upon consideration of the Department of Commerce’s (“Commerce”) Final Results of

Redetermination Pursuant to United States Court of International Trade Remand Order, Altos

Hornos de Mexico, S.A. de C.V. v. United States, et al., Court No. 01-00018 (April 15, 2002)

(“Remand Determination”); and pursuant to the telephonic status conference held on Monday,

October 7, 2002, with Kermit Alstead, appearing on behalf of Plaintiff Altos Hornos de Mexico,

S.A. de C.V.; Lucius B. Lau and Scott McBride appearing on behalf of the United States; and

Jennifer Ricardi appearing on behalf of Defendant-Intervenors Bethlehem Steel Corporation and

United States Steel Corporation; at which time each party indicated it had not filed comments

contesting Commerce’s Remand Determination; the Court having reviewed Commerce’s

Remand Determination and all pleadings and papers on file herein, and good cause appearing

therefore, it is hereby

ORDERED that Commerce’s Remand Determination is in accordance with this court’s

Remand Order of April 15, 2002; and it is further

ORDERED that the Final Results of Redetermination Pursuant to United States Court of

International Trade Remand Order, Altos Hornos de Mexico, S.A. de C.V. v. United States, et
al., Court No. 01-00018 (April 15, 2002), issued on June 28, 2002, are sustained. 

__________________________

Evan J. Wallach, Judge

Dated: November 12, 2002

New York, New York
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report of Pharmaceutical Product
Development, Inc. (PPD) on Form 10-Q for the period ended June 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Fredric N. Eshelman, Chief Executive Officer of PPD, hereby
certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:



1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and



2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of PPD as of, and for, the periods presented in the Report.



Date: August 6, 2003



|                                           
|-------------------------------------------
|/s/ Fredric N. Eshelman                    
|Fredric N. Eshelman Chief Executive Officer
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of registration.
 SUMMARY: S & B Pharma, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants S & B Pharma, Inc. registration as a manufacturer of those controlled substances.


SUPPLEMENTARY INFORMATION: By notice dated July 1, 2014, and published in the 
                    **Federal Register**
                     on July 8, 2014, 79 FR 38564, S & B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of S & B Pharma, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed: Controlled
                             Substance
ScheduleGamma Hydroxybutyric Acid (2010)
ITetrahydrocannabinols (7370)
IMethamphetamine (1105)
IIPentobarbital (2270)
IINabilone (7379)
II4-Anilino-N-phenethyl-4-piperidine (ANPP) (8333)
IITapentadol (9780)
IIFentanyl (9801)
II
 The company plans to manufacture the listed controlled substances in bulk for use in product development and for commercial sales to its customers. Dated: January 9, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator.


[FR Doc. 2015-01287 Filed 1-23-15; 8:45 am] BILLING CODE P
EXHIBIT
      32.2





CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350,


AS
      ADOPTED PURSUANT TO SECTION 906


OF
      THE SARBANES-OXLEY ACT OF 2002





Pursuant
      to 18 U.S.C. Section 1350, the undersigned chief financial
officer
      of Mac Filmworks, Inc.
      (the “Company”), hereby certifies, to such officer’s knowledge, that the
      Company’s Annual Report on Form 10-KSB for the year ended December 31, 2007 (the
“Report”) fully complies with the requirements of Section 13(a) or Section
      15(d), as applicable, of the Securities Exchange Act of 1934 and that the
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.








/s/
DWAYNE
                DESLATTEDwayne
                Deslatte, Chief Financial OfficerDate:  March
                31, 2008
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 20-0412

IN THE MATTER OF THE MENTAL HEALTH OF:

T.A.,

Respondent and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, and 

good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including January 27, 2021, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Beth Baker

Justice, Montana Supreme Court

December 17 2020

12/17/2020

Case Number: DA 20-0412